SAREPTA THERAPEUTICS, INC revenue breakdown overview

SAREPTA THERAPEUTICS, INC revenue for the last year amounted to 39.66 B MXN, the most of which — 37.28 B MXN — came from its highest performing source at the moment, RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities, the year earlier bringing 19.45 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought SAREPTA THERAPEUTICS, INC 34.15 B MXN, and the year before that — 16.96 B MXN.